Plasma circulatory markers in male and female patients with coronary artery disease

Heart and Lung: Journal of Acute and Critical Care

Volumn 39, Issue 4, 2010, Pages 296-303

  Jha, Hem C ^a   Divya, Aabha ^b   Prasad, Jagdish ^a   Mittal, Aruna ^a  

^a SAFDARJUNG HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CORONARY ARTERY DISEASE; CORONARY RISK; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SMOKING;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CORONARY ARTERY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INDIA; INFLAMMATION; INTERFERONS; INTERLEUKINS; MALE; MIDDLE AGED; QUESTIONNAIRES; SEX FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954311087     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2009.10.005     Document Type: Article

References (37)

1. Hackam D.G., Anand S.S. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA 2003, 290:932-940.
2. Ross R. Atherosclerosis- an inflammatory disease. N Engl J Med 1999, 340:115-126.
3. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
4. Blake G.J., Ridker P.M. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002, 252:283-294.
5. Hebenstreit D., Wirnsberger G., Horejs-Hoeck J., et al. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 2006, 17:173-188.
6. Mallika V., Goswami B., Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology 2007, 58:513-522.
7. Wuthrich R.P., Jevnikar A.M., Takei F., et al. Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. Am J Pathol 1990, 136:441-450.
8. Li J.J., Fang C.H. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses 2004, 62:499-506.
9. Walpola P.L., Gotlieb A.I., Cybulsky M.I., et al. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler Thromb Vasc Biol 1995, 5:2-10.
10. Kosuge M., Ebina T., Hibi K., et al. Value of serial C-reactive protein measurements in non ST-segment elevation acute coronary syndromes. Clin Cardiol 2008, 31:437-442.
11. Georges J.L., Loukac V., Poirier O., et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. J Mol Med 2001, 79:300-305.
12. Blake G.J., Ridker P.M. Novel clinical markers of vascular wall inflammation. Circ Res 2001, 89:763-771.
13. Khreiss T., József L., Potempa L.A., et al. Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Circ Res 2005, 97:690-697.
14. Bermudez E.A., Rifai N., Buring J., et al. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002, 22:1668-1673.
15. Ridker P.M., Hennekens C.H., Buring J.E., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
16. Napoli C., Lerman L.O., Nigris F., et al. Rethinking primary prevention of atherosclerosis-related diseases. Circulation 2006, 114:2517-2527.
17. Pai J.K., Hankinson S.E., Thadhani R., et al. Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis 2006, 186:113-120.
18. de Maat M.P.M., Kluft C. The association between inflammation markers, coronary artery disease and smoking. Vascul Pharmacol 2002, 39:137-139.
19. Hermann C., Graf K., Groh A., et al. Comparison of eleven commercial tests for chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol 2002, 40:1603-1609.
20. Hoffman M., Blum A., Baruch R., et al. Leukocytes and coronary heart disease. Atherosclerosis 2004, 172:1-6.
21. Sengoelge G., Födinger M., Skoupy S., et al. Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE modified fibronectin. Kidney Int 1998, 54:1637-1651.
22. Srinivasan S., Yeh M., Danziger E.C., et al. Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ Res 2003, 92:371-377.
23. Pradhan A.D., Cook N.R., Buring J.E., Manson J.E., Ridker P.M. C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol 2003, 23:650-655.
24. Kokura S., Wolf R.E., Yoshikawa T., Granger D.N., Aw T.Y. Postanoxic T lymphocyte-endothelial cell interactions induce tumor necrosis factor-production and neutrophil adhesion. Circ Res 2000, 86:1237-1244.
25. Tan J., Hua Q., Gao J., et al. Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction. Clin Cardiol 2008, 31:413-418.
26. Zairis M.N., Adamopoulou E.N., Manousakis S.J., et al. The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiac mortality in patients with acute coronary syndromes. Atherosclerosis 2007, 194:397-402.
27. Zurawski S.M., Vega F., Huyghe B., et al. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 1993, 12:2663-2670.
28. Gabay C., Porter B., Guenette D., et al. Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1 on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. Blood 1999, 93:1299-1307.
29. Johnson L.A., Clasper S., Holt A.P., et al. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med 2006, 203:2763-2777.
30. Kawanami D., Maemura K., Takeda N., et al. C-reactive protein induces VCAM-1 gene expression through NF-κB activation in vascular endothelial cells. Atherosclerosis 2006, 185:39-46.
31. Luscinskas F.W., Gimbrone M.A. Endothelial dependent mechanism in chronic inflammatory leukocyte recruitment. Annu Rev Med 1996, 47:413-421.
32. Muller W.A. Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest 2002, 82:521-533.
33. Beekhuizen H., Gevel J.S. Endothelial cell adhesion molecules in inflammation and postischemic reperfusion injury. Transplant Proc 1998, 30:4251-4256.
34. Kokura S., Wolf R.E., Yoshikawa T., et al. Postanoxic T lymphocyte-endothelial cell interactions induce tumor necrosis factor-a production and neutrophil adhesion. Circ Res 2000, 86:1237-1244.
35. Girndt M., Köhler H. Interleukin-10 (IL-10): an update on its relevance for cardiovascular risk. Nephrol Dial Transplant 2003, 18:1976-1979.
36. Aronson F.L., Kimball A.W. Coronary heart disease mortality and alcohol consumption Framingham. Am J Epidemiol 1986, 124:481-489.
37. Alho H., Sillanaukee P., Kalela A., et al. Alcohol misuse increases serum antibodies to oxidized LDL and CRP. Alcohol Alcohol 2004, 39:312-315.